Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
about
Erythropoietin for cancer-associated malignant anemia: A meta-analysis.A dimeric peptide with erythropoiesis-stimulating activity uniquely affects erythropoietin receptor ligation and cell surface expression.Investigational therapies for renal disease-induced anemia.EPOR2/βcR2-independendent effects of low-dose epoetin-α in porcine liver transplantation.Different effects of granulocyte colony-stimulating factor and erythropoietin on erythropoiesis.
P2860
Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
@en
type
label
Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
@en
prefLabel
Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
@en
P2093
P2860
P1476
Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
@en
P2093
Don M Wojchowski
Edward Jachimowicz
Nicole Rainville
P2860
P304
P356
10.1517/14728222.2016.1090975
P407
P577
2015-09-30T00:00:00Z